Punch & Associates Investment Management, Inc. Harvard Bioscience Inc Transaction History
Punch & Associates Investment Management, Inc.
- $1.68 Billion
- Q4 2024
A detailed history of Punch & Associates Investment Management, Inc. transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Punch & Associates Investment Management, Inc. holds 2,755,600 shares of HBIO stock, worth $992,016. This represents 0.35% of its overall portfolio holdings.
Number of Shares
2,755,600
Previous 2,772,700
0.62%
Holding current value
$992,016
Previous $7.46 Million
22.04%
% of portfolio
0.35%
Previous 0.44%
Shares
18 transactions
Others Institutions Holding HBIO
# of Institutions
96Shares Held
31.1MCall Options Held
0Put Options Held
15K-
Amh Equity LTD3.39MShares$1.22 Million3.14% of portfolio
-
Black Rock Inc. New York, NY2.84MShares$1.02 Million0.0% of portfolio
-
Harvey Partners, LLC Tarrytown, NY2.68MShares$965,8800.66% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.16MShares$776,8270.0% of portfolio
-
Royce & Associates LP1.97MShares$707,4410.04% of portfolio
About HARVARD BIOSCIENCE INC
- Ticker HBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 41,636,500
- Market Cap $15M
- Description
- Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...